医学
观察研究
病危
重症监护医学
多中心研究
内科学
随机对照试验
作者
Annika Reintam Blaser,Martin Padar,Merli Mändul,Gunnar Elke,Christoph Engel,Krista Fischer,Mikhaël Giabicani,T. Gold,Benjamin Hess,M. Hiesmayr,Stephan M. Jakob,Cecilia Loudet,Dennis M. Meesters,Wasineenart Mongkolpun,Cathérine Paugam‐Burtz,Martijn Poeze,Jean‐Charles Preiser,Mattias Renberg,Olav Rooijackers,Kadri Tamme
标识
DOI:10.1016/j.clnu.2021.07.015
摘要
SummaryBackground & aimsTo develop a five grade score (0–4 points) for the assessment of gastrointestinal (GI) dysfunction in adult critically ill patients.MethodsThis prospective multicenter observational study enrolled consecutive adult patients admitted to 11 intensive care units in nine countries. At all sites, daily clinical data with emphasis on GI clinical symptoms were collected and intra-abdominal pressure measured. In five out of 11 sites, the biomarkers citrulline and intestinal fatty acid-binding protein (I-FABP) were measured additionally. Cox models with time-dependent scores were used to analyze associations with 28- and 90-day mortality. The models were estimated with stratification for study center.ResultsWe included 540 patients (224 with biomarker measurements) with median age of 65 years (range 18–94), the Simplified Acute Physiology Score II score of 38 (interquartile range 26–53) points, and Sequential Organ Failure Assessment (SOFA) score of 6 (interquartile range 3–9) points at admission. Median ICU length of stay was 3 (interquartile range 1–6) days and 90-day mortality 18.9%.A new five grade Gastrointestinal Dysfunction Score (GIDS) was developed based on the rationale of the previously developed Acute GI Injury (AGI) grading. Citrulline and I-FABP did not prove their potential for scoring of GI dysfunction in critically ill. GIDS was independently associated with 28- and 90-day mortality when added to SOFA total score (HR 1.40; 95%CI 1.07–1.84 and HR 1.40; 95%CI 1.02–1.79, respectively) or to a model containing all SOFA subscores (HR 1.48; 95%CI 1.13–1.92 and HR 1.47; 95%CI 1.15–1.87, respectively), improving predictive power of SOFA score in all analyses.ConclusionsThe newly developed GIDS is additive to SOFA score in prediction of 28- and 90-day mortality. The clinical usefulness of this score should be validated prospectively.Trial registrationNCT02613000, retrospectively registered 24 November 2015.
科研通智能强力驱动
Strongly Powered by AbleSci AI